WisdomTree WTI Crude Oil - GBP Daily Hedged
WisdomTree WTI Crude Oil - GBP Daily Hedged (PCRD.L) Stock Competitors & Peer Comparison
See (PCRD.L) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PCRD.L | £313.25 | +4.36% | 260.5M | N/A | N/A | N/A |
| IUSA.L | £4,778.75 | +0.61% | 1.4T | N/A | N/A | +100.20% |
| SSAC.L | £7,498.00 | +0.52% | 1.1T | N/A | N/A | N/A |
| SMEA.L | £7,490.00 | -0.21% | 959.2B | N/A | N/A | N/A |
| IITU.L | £2,879.00 | +1.20% | 941B | N/A | N/A | N/A |
| XESC.L | £8,108.00 | +0.87% | 849.5B | N/A | N/A | N/A |
| XESX.L | £4,921.75 | +0.86% | 849.3B | N/A | N/A | +2.66% |
| MEUD.L | £22,770.00 | -0.02% | 787.5B | N/A | N/A | N/A |
| UB0D.L | £2,248.50 | +0.18% | 739.8B | N/A | N/A | +1.70% |
| CNAL.L | £12,311.00 | +1.20% | 694.6B | -11.49 | -£10.70 | N/A |
Stock Comparison
PCRD.L vs IUSA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IUSA.L has a market cap of 1.4T. Regarding current trading prices, PCRD.L is priced at £313.25, while IUSA.L trades at £4,778.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IUSA.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IUSA.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to IUSA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IUSA.L's competition here
PCRD.L vs SSAC.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SSAC.L has a market cap of 1.1T. Regarding current trading prices, PCRD.L is priced at £313.25, while SSAC.L trades at £7,498.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SSAC.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SSAC.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SSAC.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SSAC.L's competition here
PCRD.L vs SMEA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SMEA.L has a market cap of 959.2B. Regarding current trading prices, PCRD.L is priced at £313.25, while SMEA.L trades at £7,490.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SMEA.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SMEA.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SMEA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SMEA.L's competition here
PCRD.L vs IITU.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IITU.L has a market cap of 941B. Regarding current trading prices, PCRD.L is priced at £313.25, while IITU.L trades at £2,879.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IITU.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IITU.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to IITU.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check IITU.L's competition here
PCRD.L vs XESC.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XESC.L has a market cap of 849.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while XESC.L trades at £8,108.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XESC.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XESC.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XESC.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XESC.L's competition here
PCRD.L vs XESX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XESX.L has a market cap of 849.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while XESX.L trades at £4,921.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XESX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XESX.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to XESX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XESX.L's competition here
PCRD.L vs MEUD.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, MEUD.L has a market cap of 787.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while MEUD.L trades at £22,770.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas MEUD.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to MEUD.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to MEUD.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check MEUD.L's competition here
PCRD.L vs UB0D.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, UB0D.L has a market cap of 739.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while UB0D.L trades at £2,248.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas UB0D.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to UB0D.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to UB0D.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check UB0D.L's competition here
PCRD.L vs CNAL.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CNAL.L has a market cap of 694.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while CNAL.L trades at £12,311.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CNAL.L's P/E ratio is -11.49. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CNAL.L's ROE of +0.32%. Regarding short-term risk, PCRD.L is more volatile compared to CNAL.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CNAL.L's competition here
PCRD.L vs IWRD.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IWRD.L has a market cap of 599.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while IWRD.L trades at £6,574.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IWRD.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IWRD.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IWRD.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IWRD.L's competition here
PCRD.L vs XMMS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XMMS.L has a market cap of 549.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while XMMS.L trades at £5,019.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XMMS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XMMS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XMMS.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XMMS.L's competition here
PCRD.L vs XDAX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XDAX.L has a market cap of 545.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while XDAX.L trades at £19,658.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XDAX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XDAX.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to XDAX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XDAX.L's competition here
PCRD.L vs XMUS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XMUS.L has a market cap of 518.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while XMUS.L trades at £14,292.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XMUS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XMUS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XMUS.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XMUS.L's competition here
PCRD.L vs MXWS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, MXWS.L has a market cap of 516.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while MXWS.L trades at £9,703.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas MXWS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to MXWS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to MXWS.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check MXWS.L's competition here
PCRD.L vs PHGP.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, PHGP.L has a market cap of 507B. Regarding current trading prices, PCRD.L is priced at £313.25, while PHGP.L trades at £23,076.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas PHGP.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to PHGP.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to PHGP.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check PHGP.L's competition here
PCRD.L vs GLDA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, GLDA.L has a market cap of 494.4B. Regarding current trading prices, PCRD.L is priced at £313.25, while GLDA.L trades at £9,830.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas GLDA.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to GLDA.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to GLDA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check GLDA.L's competition here
PCRD.L vs XMEU.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XMEU.L has a market cap of 480.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while XMEU.L trades at £8,556.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XMEU.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XMEU.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XMEU.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XMEU.L's competition here
PCRD.L vs UC44.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, UC44.L has a market cap of 466.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while UC44.L trades at £13,302.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas UC44.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to UC44.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to UC44.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check UC44.L's competition here
PCRD.L vs CS51.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CS51.L has a market cap of 458.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while CS51.L trades at £17,698.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CS51.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CS51.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CS51.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CS51.L's competition here
PCRD.L vs IEEM.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IEEM.L has a market cap of 403.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while IEEM.L trades at £3,672.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IEEM.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IEEM.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IEEM.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IEEM.L's competition here
PCRD.L vs EUE.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, EUE.L has a market cap of 394B. Regarding current trading prices, PCRD.L is priced at £313.25, while EUE.L trades at £4,796.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas EUE.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to EUE.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to EUE.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check EUE.L's competition here
PCRD.L vs UB32.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, UB32.L has a market cap of 389.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while UB32.L trades at £9,275.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas UB32.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to UB32.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to UB32.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check UB32.L's competition here
PCRD.L vs SEMA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SEMA.L has a market cap of 355.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while SEMA.L trades at £3,465.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SEMA.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SEMA.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SEMA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SEMA.L's competition here
PCRD.L vs CACX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CACX.L has a market cap of 347.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while CACX.L trades at £6,868.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CACX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CACX.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CACX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CACX.L's competition here
PCRD.L vs XSX6.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XSX6.L has a market cap of 328.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while XSX6.L trades at £12,059.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XSX6.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XSX6.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XSX6.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XSX6.L's competition here
PCRD.L vs IWFQ.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IWFQ.L has a market cap of 317.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while IWFQ.L trades at £5,552.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IWFQ.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IWFQ.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to IWFQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check IWFQ.L's competition here
PCRD.L vs GBSS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, GBSS.L has a market cap of 301.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while GBSS.L trades at £22,723.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas GBSS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to GBSS.L's ROE of N/A. Regarding short-term risk, PCRD.L is less volatile compared to GBSS.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check GBSS.L's competition here
PCRD.L vs IWFV.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IWFV.L has a market cap of 282.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while IWFV.L trades at £3,792.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IWFV.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IWFV.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IWFV.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IWFV.L's competition here
PCRD.L vs SGBX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SGBX.L has a market cap of 276.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while SGBX.L trades at £23,726.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SGBX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SGBX.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to SGBX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SGBX.L's competition here
PCRD.L vs CEA1.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CEA1.L has a market cap of 267.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while CEA1.L trades at £15,860.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CEA1.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CEA1.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CEA1.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CEA1.L's competition here
PCRD.L vs RBTX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, RBTX.L has a market cap of 255.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while RBTX.L trades at £1,160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas RBTX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to RBTX.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to RBTX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check RBTX.L's competition here
PCRD.L vs ISPY.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, ISPY.L has a market cap of 254.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while ISPY.L trades at £2,378.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas ISPY.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to ISPY.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to ISPY.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check ISPY.L's competition here
PCRD.L vs CPJ1.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CPJ1.L has a market cap of 246.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while CPJ1.L trades at £15,916.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CPJ1.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CPJ1.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to CPJ1.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check CPJ1.L's competition here
PCRD.L vs SUES.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SUES.L has a market cap of 242.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while SUES.L trades at £640.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SUES.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SUES.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SUES.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SUES.L's competition here
PCRD.L vs JRDE.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, JRDE.L has a market cap of 241.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while JRDE.L trades at £3,694.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas JRDE.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to JRDE.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to JRDE.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check JRDE.L's competition here
PCRD.L vs JERE.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, JERE.L has a market cap of 241.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while JERE.L trades at £3,983.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas JERE.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to JERE.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to JERE.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check JERE.L's competition here
PCRD.L vs IWFM.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IWFM.L has a market cap of 231B. Regarding current trading prices, PCRD.L is priced at £313.25, while IWFM.L trades at £6,827.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IWFM.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IWFM.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IWFM.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IWFM.L's competition here
PCRD.L vs PHSP.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, PHSP.L has a market cap of 222.2B. Regarding current trading prices, PCRD.L is priced at £313.25, while PHSP.L trades at £2,581.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas PHSP.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to PHSP.L's ROE of N/A. Regarding short-term risk, PCRD.L and PHSP.L have similar daily volatility (1.12).Check PHSP.L's competition here
PCRD.L vs HMEF.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, HMEF.L has a market cap of 212.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while HMEF.L trades at £931.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas HMEF.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to HMEF.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to HMEF.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check HMEF.L's competition here
PCRD.L vs IUQF.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IUQF.L has a market cap of 200.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while IUQF.L trades at £1,168.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IUQF.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IUQF.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IUQF.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IUQF.L's competition here
PCRD.L vs XXSC.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XXSC.L has a market cap of 193.4B. Regarding current trading prices, PCRD.L is priced at £313.25, while XXSC.L trades at £5,699.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XXSC.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XXSC.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XXSC.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XXSC.L's competition here
PCRD.L vs SPGP.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SPGP.L has a market cap of 191.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while SPGP.L trades at £1,804.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SPGP.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SPGP.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to SPGP.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check SPGP.L's competition here
PCRD.L vs XDEV.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XDEV.L has a market cap of 187.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while XDEV.L trades at £3,900.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XDEV.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XDEV.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XDEV.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XDEV.L's competition here
PCRD.L vs UIFS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, UIFS.L has a market cap of 186.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while UIFS.L trades at £1,162.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas UIFS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to UIFS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to UIFS.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check UIFS.L's competition here
PCRD.L vs SOYU.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SOYU.L has a market cap of 175.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while SOYU.L trades at £299.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SOYU.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SOYU.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SOYU.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SOYU.L's competition here
PCRD.L vs CEUR.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CEUR.L has a market cap of 174.2B. Regarding current trading prices, PCRD.L is priced at £313.25, while CEUR.L trades at £31,727.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CEUR.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CEUR.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CEUR.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CEUR.L's competition here
PCRD.L vs XDEQ.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XDEQ.L has a market cap of 162.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while XDEQ.L trades at £5,657.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XDEQ.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XDEQ.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XDEQ.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XDEQ.L's competition here
PCRD.L vs CU1.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CU1.L has a market cap of 159.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while CU1.L trades at £49,382.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CU1.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CU1.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CU1.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CU1.L's competition here
PCRD.L vs IEFV.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IEFV.L has a market cap of 155.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while IEFV.L trades at £908.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IEFV.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IEFV.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IEFV.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IEFV.L's competition here
PCRD.L vs PRIR.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, PRIR.L has a market cap of 153.2B. Regarding current trading prices, PCRD.L is priced at £313.25, while PRIR.L trades at £1,495.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas PRIR.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to PRIR.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to PRIR.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check PRIR.L's competition here
PCRD.L vs GBSP.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, GBSP.L has a market cap of 147.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while GBSP.L trades at £1,694.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas GBSP.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to GBSP.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to GBSP.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check GBSP.L's competition here
PCRD.L vs WATL.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, WATL.L has a market cap of 146.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while WATL.L trades at £6,027.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas WATL.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to WATL.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to WATL.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check WATL.L's competition here
PCRD.L vs ISP6.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, ISP6.L has a market cap of 145.2B. Regarding current trading prices, PCRD.L is priced at £313.25, while ISP6.L trades at £6,861.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas ISP6.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to ISP6.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to ISP6.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check ISP6.L's competition here
PCRD.L vs IPRP.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IPRP.L has a market cap of 144.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while IPRP.L trades at £2,657.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IPRP.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IPRP.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IPRP.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IPRP.L's competition here
PCRD.L vs CUS1.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CUS1.L has a market cap of 138.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while CUS1.L trades at £40,827.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CUS1.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CUS1.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CUS1.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CUS1.L's competition here
PCRD.L vs CG1.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CG1.L has a market cap of 137.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while CG1.L trades at £37,232.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CG1.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CG1.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CG1.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CG1.L's competition here
PCRD.L vs XCX6.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XCX6.L has a market cap of 136.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while XCX6.L trades at £1,438.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XCX6.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XCX6.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XCX6.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XCX6.L's competition here
PCRD.L vs UC79.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, UC79.L has a market cap of 134.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while UC79.L trades at £1,183.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas UC79.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to UC79.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to UC79.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check UC79.L's competition here
PCRD.L vs GILS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, GILS.L has a market cap of 132B. Regarding current trading prices, PCRD.L is priced at £313.25, while GILS.L trades at £10,150.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas GILS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to GILS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to GILS.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check GILS.L's competition here
PCRD.L vs CB5.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CB5.L has a market cap of 130.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while CB5.L trades at £4,220.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CB5.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CB5.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to CB5.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check CB5.L's competition here
PCRD.L vs CSPX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CSPX.L has a market cap of 126.4B. Regarding current trading prices, PCRD.L is priced at £313.25, while CSPX.L trades at £679.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CSPX.L's P/E ratio is 27.53. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CSPX.L's ROE of N/A. Regarding short-term risk, PCRD.L is less volatile compared to CSPX.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check CSPX.L's competition here
PCRD.L vs GSPX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, GSPX.L has a market cap of 126.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while GSPX.L trades at £10.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas GSPX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to GSPX.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to GSPX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check GSPX.L's competition here
PCRD.L vs INFL.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, INFL.L has a market cap of 126B. Regarding current trading prices, PCRD.L is priced at £313.25, while INFL.L trades at £10,069.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas INFL.L's P/E ratio is 4.18. In terms of profitability, PCRD.L's ROE is +0.00%, compared to INFL.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to INFL.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check INFL.L's competition here
PCRD.L vs XZEU.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XZEU.L has a market cap of 125.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while XZEU.L trades at £2,825.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XZEU.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XZEU.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XZEU.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XZEU.L's competition here
PCRD.L vs SP5G.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SP5G.L has a market cap of 125.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while SP5G.L trades at £216.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SP5G.L's P/E ratio is 67.35. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SP5G.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SP5G.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SP5G.L's competition here
PCRD.L vs XDEM.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XDEM.L has a market cap of 124B. Regarding current trading prices, PCRD.L is priced at £313.25, while XDEM.L trades at £5,748.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XDEM.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XDEM.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to XDEM.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XDEM.L's competition here
PCRD.L vs IGSG.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IGSG.L has a market cap of 122.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while IGSG.L trades at £6,197.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IGSG.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IGSG.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IGSG.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IGSG.L's competition here
PCRD.L vs H50E.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, H50E.L has a market cap of 122.2B. Regarding current trading prices, PCRD.L is priced at £313.25, while H50E.L trades at £4,998.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas H50E.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to H50E.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to H50E.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check H50E.L's competition here
PCRD.L vs IJPN.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IJPN.L has a market cap of 121.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while IJPN.L trades at £1,420.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IJPN.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IJPN.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IJPN.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IJPN.L's competition here
PCRD.L vs 0GWB.IL Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, 0GWB.IL has a market cap of 121.1B. Regarding current trading prices, PCRD.L is priced at £313.25, while 0GWB.IL trades at £492.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas 0GWB.IL's P/E ratio is 15.86. In terms of profitability, PCRD.L's ROE is +0.00%, compared to 0GWB.IL's ROE of +0.06%. Regarding short-term risk, PCRD.L is less volatile compared to 0GWB.IL. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check 0GWB.IL's competition here
PCRD.L vs XRSG.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XRSG.L has a market cap of 116.4B. Regarding current trading prices, PCRD.L is priced at £313.25, while XRSG.L trades at £24,957.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XRSG.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XRSG.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to XRSG.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check XRSG.L's competition here
PCRD.L vs IWDG.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IWDG.L has a market cap of 115.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while IWDG.L trades at £1,040.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IWDG.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IWDG.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to IWDG.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IWDG.L's competition here
PCRD.L vs IWDA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IWDA.L has a market cap of 115B. Regarding current trading prices, PCRD.L is priced at £313.25, while IWDA.L trades at £120.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IWDA.L's P/E ratio is 24.15. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IWDA.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IWDA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IWDA.L's competition here
PCRD.L vs JRDM.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, JRDM.L has a market cap of 113.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while JRDM.L trades at £2,473.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas JRDM.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to JRDM.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to JRDM.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check JRDM.L's competition here
PCRD.L vs IEUX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IEUX.L has a market cap of 112.7B. Regarding current trading prices, PCRD.L is priced at £313.25, while IEUX.L trades at £4,075.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IEUX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IEUX.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IEUX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IEUX.L's competition here
PCRD.L vs PRIC.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, PRIC.L has a market cap of 110.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while PRIC.L trades at £1,654.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas PRIC.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to PRIC.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to PRIC.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check PRIC.L's competition here
PCRD.L vs DAXX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, DAXX.L has a market cap of 107.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while DAXX.L trades at £19,172.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas DAXX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to DAXX.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to DAXX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check DAXX.L's competition here
PCRD.L vs EQSG.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, EQSG.L has a market cap of 107.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while EQSG.L trades at £5,488.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas EQSG.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to EQSG.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to EQSG.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check EQSG.L's competition here
PCRD.L vs XLKQ.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XLKQ.L has a market cap of 104.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while XLKQ.L trades at £59,225.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XLKQ.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XLKQ.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to XLKQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check XLKQ.L's competition here
PCRD.L vs WQDS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, WQDS.L has a market cap of 103.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while WQDS.L trades at £574.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas WQDS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to WQDS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to WQDS.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check WQDS.L's competition here
PCRD.L vs COMM.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, COMM.L has a market cap of 103.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while COMM.L trades at £554.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas COMM.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to COMM.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to COMM.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check COMM.L's competition here
PCRD.L vs CSCA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CSCA.L has a market cap of 102.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while CSCA.L trades at £18,006.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CSCA.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CSCA.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CSCA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CSCA.L's competition here
PCRD.L vs TRXS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, TRXS.L has a market cap of 99B. Regarding current trading prices, PCRD.L is priced at £313.25, while TRXS.L trades at £3,366.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas TRXS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to TRXS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to TRXS.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check TRXS.L's competition here
PCRD.L vs IUKD.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IUKD.L has a market cap of 96.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while IUKD.L trades at £848.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IUKD.L's P/E ratio is 14.89. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IUKD.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IUKD.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IUKD.L's competition here
PCRD.L vs MTIX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, MTIX.L has a market cap of 96.4B. Regarding current trading prices, PCRD.L is priced at £313.25, while MTIX.L trades at £14,407.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas MTIX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to MTIX.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to MTIX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check MTIX.L's competition here
PCRD.L vs PRIJ.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, PRIJ.L has a market cap of 95.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while PRIJ.L trades at £2,481.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas PRIJ.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to PRIJ.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to PRIJ.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check PRIJ.L's competition here
PCRD.L vs IGUS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IGUS.L has a market cap of 94.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while IGUS.L trades at £14,557.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IGUS.L's P/E ratio is 27.47. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IGUS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IGUS.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IGUS.L's competition here
PCRD.L vs RIEG.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, RIEG.L has a market cap of 94.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while RIEG.L trades at £1,464.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas RIEG.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to RIEG.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to RIEG.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check RIEG.L's competition here
PCRD.L vs IMV.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IMV.L has a market cap of 94.9B. Regarding current trading prices, PCRD.L is priced at £313.25, while IMV.L trades at £5,780.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IMV.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IMV.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IMV.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IMV.L's competition here
PCRD.L vs CSP1.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CSP1.L has a market cap of 94.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while CSP1.L trades at £51,174.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CSP1.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CSP1.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to CSP1.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check CSP1.L's competition here
PCRD.L vs INAA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, INAA.L has a market cap of 94.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while INAA.L trades at £8,902.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas INAA.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to INAA.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to INAA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check INAA.L's competition here
PCRD.L vs SPEX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SPEX.L has a market cap of 92.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while SPEX.L trades at £4,722.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SPEX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SPEX.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SPEX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SPEX.L's competition here
PCRD.L vs SPES.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SPES.L has a market cap of 92.5B. Regarding current trading prices, PCRD.L is priced at £313.25, while SPES.L trades at £4,445.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SPES.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SPES.L's ROE of N/A. Regarding short-term risk, PCRD.L is more volatile compared to SPES.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SPES.L's competition here
PCRD.L vs EQDS.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, EQDS.L has a market cap of 92.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while EQDS.L trades at £548.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas EQDS.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to EQDS.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to EQDS.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check EQDS.L's competition here
PCRD.L vs UB45.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, UB45.L has a market cap of 91.8B. Regarding current trading prices, PCRD.L is priced at £313.25, while UB45.L trades at £6,305.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas UB45.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to UB45.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to UB45.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check UB45.L's competition here
PCRD.L vs CRPX.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, CRPX.L has a market cap of 91.4B. Regarding current trading prices, PCRD.L is priced at £313.25, while CRPX.L trades at £13,290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas CRPX.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to CRPX.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to CRPX.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check CRPX.L's competition here
PCRD.L vs IDVY.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, IDVY.L has a market cap of 90.3B. Regarding current trading prices, PCRD.L is priced at £313.25, while IDVY.L trades at £1,930.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas IDVY.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to IDVY.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to IDVY.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check IDVY.L's competition here
PCRD.L vs XDN0.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, XDN0.L has a market cap of 87.6B. Regarding current trading prices, PCRD.L is priced at £313.25, while XDN0.L trades at £4,067.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas XDN0.L's P/E ratio is 17.52. In terms of profitability, PCRD.L's ROE is +0.00%, compared to XDN0.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is less volatile compared to XDN0.L. This indicates potentially lower risk in terms of short-term price fluctuations for PCRD.L.Check XDN0.L's competition here
PCRD.L vs SWDA.L Comparison July 2025
PCRD.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRD.L stands at 260.5M. In comparison, SWDA.L has a market cap of 86.2B. Regarding current trading prices, PCRD.L is priced at £313.25, while SWDA.L trades at £9,045.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRD.L currently has a P/E ratio of N/A, whereas SWDA.L's P/E ratio is N/A. In terms of profitability, PCRD.L's ROE is +0.00%, compared to SWDA.L's ROE of +0.00%. Regarding short-term risk, PCRD.L is more volatile compared to SWDA.L. This indicates potentially higher risk in terms of short-term price fluctuations for PCRD.L.Check SWDA.L's competition here